ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American …

LA Fleisher, JA Beckman, KA Brown, H Calkins… - Circulation, 2007 - Am Heart Assoc
It is important that the medical profession play a significant role in critically evaluating the
use of diagnostic procedures and therapies as they are introduced and tested in the …

Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association …

CL Grines, RO Bonow, DE Casey Jr, TJ Gardner… - Circulation, 2007 - Am Heart Assoc
Dual antiplatelet therapy with aspirin and a thienopyridine has been shown to reduce
cardiac events after coronary stenting. However, many patients and healthcare providers …

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

J Daemen, P Wenaweser, K Tsuchida, L Abrecht… - The Lancet, 2007 - thelancet.com
Background Stent thrombosis is a safety concern associated with use of drug-eluting stents.
Little is known about occurrence of stent thrombosis more than 1 year after implantation of …

Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden

B Lagerqvist, SK James, U Stenestrand… - … England Journal of …, 2007 - Mass Medical Soc
Background Recent reports have indicated that there may be an increased risk of late stent
thrombosis with the use of drug-eluting stents, as compared with bare-metal stents. Methods …

Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis

T Inoue, K Croce, T Morooka, M Sakuma… - JACC: Cardiovascular …, 2011 - jacc.org
The cellular and molecular processes that control vascular injury responses after
percutaneous coronary intervention involve a complex interplay among vascular cells and …

Coronary stents: current status

S Garg, PW Serruys - Journal of the American College of Cardiology, 2010 - jacc.org
Coronary artery stents revolutionized the practice of interventional cardiology after they were
first introduced in the mid-1980s. Since then, there have been significant developments in …

2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care …

American College of Cardiology Foundation… - Journal of the American …, 2009 - jacc.org
It is essential that the medical profession play a significant role in critically evaluating the use
of diagnostic procedures and therapies as they are introduced and tested in the detection …

Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

M Sabate, A Cequier, A Iñiguez, A Serra… - The Lancet, 2012 - thelancet.com
Background Everolimus-eluting stent (EES) reduces the risk of restenosis in elective
percutaneous coronary intervention. However, the use of drug-eluting stent in patients with …

A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents

C Spaulding, J Daemen, E Boersma… - … England Journal of …, 2007 - Mass Medical Soc
Background Although randomized studies have shown a beneficial effect of drug-eluting
stents in reducing the risk of repeated revascularization, these trials were underpowered to …

Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden

G Sianos, MI Papafaklis, J Daemen, S Vaina… - Journal of the American …, 2007 - jacc.org
Objectives: This study sought to investigate the impact of thrombus burden on the clinical
outcome and angiographic infarct-related artery stent thrombosis (IRA-ST) in patients …